直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World

July 6, 2023

Webinar

Strafford Publications

As part of the Strafford Publications’ virtual programming, Finnegan attorneys Mark Feldstein, Cora Holt, and Kyu Yun Kim will discuss the Federal Circuit's recent GSK v. Teva decision, post-launch non-Hatch Waxman pharmaceutical litigation, and strategies and tactics regarding claim language and label language. For more information, or to register, please see Strafford’s website.

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Washington, DC

Related Professionals

Mark J. Feldstein, Ph.D.
Partner
Washington, DC
+1 202 408 4092
Email
Cora R. Holt
Partner
Washington, DC
+1 202 408 4334
Email

Related Insights

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

2026 TIPA International Symposium

October 30, 2026

Taipei City

Conference

LES 2026 Annual Meeting

October 18-21, 2026

San Diego

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Conference

2026 AIPPI World Congress

October 7-10, 2026

Hamburg

Federal Circuit IP Blog

Federal Circuit Affirms Written Description Support, Vacates Mooted Non-Obviousness Finding

October 5, 2026

Articles

Beyond Hikma: Patent Prosecution Strategies  for Anticipating Skinny-Label Generics  in Pharmaceutical Patent Portfolios

September 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP